4 February 2019 – TogetHER and partners hosted a webinar today on a groundbreaking study by Global Good, the National Cancer Institute, and the National Library of Medicine that found Automated Visual Evaluation (AVE) can visually recognize cervical pre-cancerous lesions better than a human expert.

---

Cervical cancer is the fourth most common cancer in women globally and is the leading form of deadly cancer in women in low-income settings. AVE has the potential to greatly improve screening for cervical cancer, particularly in low-resource settings.

Speakers were:

• Ben Wilson, Director, Center for Intelligent Devices, Intellectual Ventures Lab
• Mark Schiffman, MD, MPH, Senior Investigator, National Cancer Institute
• Celina Schocken, Executive Director, TogetHER for Health
• Noni Gachuhi, Women’s Health Lead, Global Health Technologies, Global Good